-
- Posts: 30
- Joined: Fri Oct 01, 2004 1:44 pm
When evaluating recoveries (off of a standard curve) at or near the LOQ for a method, when I use y=mx recoveries are approximately 88-90%. When I use y=mx+b recoveries are approximately 97-99%.
This is a pharma method and I have never had to use y=mx +b before.
The method analyzes an API degradant (small molecule) @ 210 nm. I assume that the better recoveries for y=mx+b is a function of noise due to the low wavelength.
Question(s):
Is the use of y=mx+b an acceptable practice?
Are there literature references (I have looked on the 'net') to support the use of y=mx+b?
If I had to justify the use of y=mx+b in the method to the FDA would they laugh at me?
thanks in advance any/all comments.
Shawn

